The results revealed lower levels of full‐length ITM2B in the carcinoma samples than those in the para‐carcinoma samples, whereas the levels of truncated‐ITM2B remained high in the carcinoma samples (Figure 1C). This evidence concerns the gene ITM2B and carcinoma.